Ordering
Available Variants5 mg
CHA.93427-5mg
Price
€157.60
Available – Dispatch in 14 days
25 mg
CHA.93427-25mg
Price
€502.40
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
5 mg | CHA.93427-5mg | €157.60 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
25 mg | CHA.93427-25mg | €502.40 |
≥90% (HPLC), mitochondria-targeted redox cycler, powder
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C39H46N2P·3I |
|---|---|
| CAS Number | 1821370-28-8 |
| Molecular Weight | 954.48 |
| UNSPSC Code | 12352200 |
| NACRES | NA.77 |
| Assay | ≥90% (HPLC) |
| Form | powder |
| Quality level | 100 |
| Storage condition | desiccated |
Safety Information Handling visibility
| Storage Class | 11 - Combustible Solids |
|---|---|
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
Technical Overview & Applications Use-case context
MitoPQ, also known as mitoquinol, is a synthetic antioxidant compound with the CAS number 1821370-28-8. It is a mitochondrially-targeted ubiquinone, designed to accumulate in the mitochondria where it can effectively neutralize reactive oxygen species and reduce oxidative stress. MitoPQ has been shown to have potential therapeutic applications in the treatment of various diseases associated with mitochondrial dysfunction, including neurodegenerative disorders and cancer. Its mechanism of action involves the scavenging of free radicals and the reduction of oxidative damage to mitochondrial membranes and DNA. Studies have demonstrated that MitoPQ can improve mitochondrial function and reduce oxidative stress in various cell types, highlighting its potential as a novel therapeutic agent for the treatment of diseases characterized by mitochondrial dysfunction. Further research is needed to fully elucidate the therapeutic potential of MitoPQ.
